Netherlands-based fintech company MODIFI targets India's pharmaceuticals, chemicals, and renewables export markets, aiming to triple operations by 2025. Its invoice factoring service provides SMEs immediate cash flow, enabling reinvestment and growth. Pharmaceuticals represent 10-15% of MODIFI’s funding, aligning with India’s $27.9 billion pharmaceutical export market. MODIFI partners with supply chain finance platforms and supports “Make in India” initiatives for SME export growth.